Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab
- DOI
- 10.1016/j.seminoncol.2026.152561
- Published
- 2026-12
- Container
- Seminars in Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.seminoncol.2026.152561,
title = {Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab},
author = {Margherita Rimini and Simone Rocchetto and Eleonora Alimenti and Giuseppe Cabibbo and Lorenza Rimassa and David J. Pinato and Alessandro Vitale and Francesca R. Ponziani and Silvia Camera and Mara Persano and Pietro Lampertico and Andrea Casadei-Gardini and Massimo Iavarone},
year = {2026},
journal = {Seminars in Oncology},
doi = {10.1016/j.seminoncol.2026.152561},
url = {https://doi.org/10.1016/j.seminoncol.2026.152561}
}RIS
TY - JOUR TI - Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab AU - Margherita Rimini AU - Simone Rocchetto AU - Eleonora Alimenti AU - Giuseppe Cabibbo AU - Lorenza Rimassa AU - David J. Pinato AU - Alessandro Vitale AU - Francesca R. Ponziani AU - Silvia Camera AU - Mara Persano AU - Pietro Lampertico AU - Andrea Casadei-Gardini AU - Massimo Iavarone PY - 2026 JO - Seminars in Oncology DO - 10.1016/j.seminoncol.2026.152561 UR - https://doi.org/10.1016/j.seminoncol.2026.152561 ER -
APA
Rimini, M., Rocchetto, S., Alimenti, E., Cabibbo, G., Rimassa, L., Pinato, D. J., Vitale, A., Ponziani, F. R., Camera, S., Persano, M., Lampertico, P., Casadei-Gardini, A., & Iavarone, M. (2026). Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab. Seminars in Oncology. https://doi.org/10.1016/j.seminoncol.2026.152561
Source records
- crossref · retrieved 2026-09-26T06:35:46.676Z